Ignite Creation Date:
2024-05-06 @ 7:47 PM
Last Modification Date:
2024-10-26 @ 3:14 PM
Study NCT ID:
NCT06136884
Status:
RECRUITING
Last Update Posted:
2024-05-16
First Post:
2023-11-07
Brief Title:
A First-In-Human Phase 1 Study Evaluating Oral TACC3 PPI Inhibitor AO-252 in Advanced Solid Tumors
Sponsor:
A2A Pharmaceuticals Inc
Organization:
A2A Pharmaceuticals Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-11-02
Start Date Type:
ACTUAL
Primary Completion Date:
2025-10-28
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-01-27
Completion Date Type:
ESTIMATED
First Submit Date:
2023-11-07
First Submit QC Date:
November 13 2023
Study First Post Date:
2023-11-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-05-14
Last Update Post Date:
2024-05-16
Last Update Post Date Type:
ACTUAL